In December 2008, Neurologix initiated its Phase 2 clinical trial for Parkinson's disease. The trial is a randomized, controlled study designed to further establish the effectiveness and the safety of the treatment. The trial is being conducted in multiple medical centers and the treatment is being infused bilaterally in trial subjects. For additional information on trial design and for enrollment opportunities, click here.

View an informative Webcast on the Phase 2 clinical trial for Parkinson's disease at www.neurologixpdtrial.com.

A brief overview of the Phase 2 Study can be viewed here.